<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Apart from autoimmune reactions, antibodies to IL-2 receptors were identified in blood sera of linear mice during <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It is indicated that in the course of <z:hpo ids='HP_0001909'>leukemia</z:hpo> establishment, there can be demonstrated antibodies capable of blocking IL-2 receptors on the membrane of activated T lymphocytes and inhibiting IL-2-dependent proliferation of T cells </plain></SENT>
<SENT sid="2" pm="."><plain>The blood sera of patients suffering from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005526'>lymphoid leukemia</z:hpo>, <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">lymphocytomas</z:e>, pure red-cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>, and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> showed antibodies against IL-2 receptors </plain></SENT>
<SENT sid="3" pm="."><plain>Out of the total number of 52 patients, 23 demonstrated those antibodies </plain></SENT>
<SENT sid="4" pm="."><plain>The data obtained should be taken into account in the patients' management using IL-2 </plain></SENT>
</text></document>